$57.0 Million
Oncorus, Inc.
Follow-On Offering
Active Bookrunner
$168.0 Million
Dyne Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$356.7 Million
American Well Corporation
Follow-On Offering
Active Bookrunner
$459.9 Million
Arvinas
Follow-On Offering
Active Bookrunner
$92.1 Million
Ocular Therapeutix, Inc.
Follow-On Offering
Active Bookrunner
$208.0 Million
ALX Oncology
Follow-On Offering
Active Bookrunner
$299.0 Million
Rocket Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$145.0 Million
Sutro Biopharma, Inc.
Follow-On Offering
Active Bookrunner
$115.0 Million
Cogent Biosciences
Follow-On Offering
Active Bookrunner
$115.0 Million
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.